To study the functions of EZH2 and AURKA in HCC, we treated HCC cell lines, including Hep3B and Huh7 cells, with an EZH2 inhibitor (gambogenic acid) and an AURKA inhibitor (alisertib) in vitro. Here, EZH2 is linked to hepatocellular carcinoma.